Last updated on November 2018

Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma


Brief description of study

A Phase III, randomised study of atezolizumab alone and in combination with chemotherapy versus chemotherapy alone in participants with untreated advanced urothelial cancer.

Clinical Study Identifier: NCT02807636

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: WO30070 ...

Chongqing Cancer Hospital
Chongqing, China

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.